NCT03373227View on ClinicalTrials.gov

Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Heart Transplant RejectionGraft FailureCompliance, Patient
Interventions
DRUG

Envarsus

Patients will take once daily Envarsus

Trial Locations (1)

75246

Baylor University Medical Center, Dallas

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER